Ignite Creation Date:
2024-05-06 @ 3:02 AM
Last Modification Date:
2024-10-26 @ 11:27 AM
Study NCT ID:
NCT02182830
Status:
COMPLETED
Last Update Posted:
2018-07-31
First Post:
2014-07-03
Brief Title:
24 Week Efficacy and Safety Study of Empagliflozin BI 10773 in Hypertensive BlackAfrican American Patients With Type 2 Diabetes Mellitus and Hypertension
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07-25
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-18
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-03
First Submit QC Date:
July 3 2014
Study First Post Date:
2014-07-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-07-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-04
Last Update Post Date:
2018-07-31
Last Update Post Date Type:
ACTUAL